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Virtually no research has examined the responses of youth
with recent-onset psychosis (ROP) to smoking-related
health warnings. We examined predictors of response and
tested hypotheses that participants with ROP would (a)
assess warnings as less effective than a healthy comparison
(HC) group, and (b) assess video warnings as more effective than pictures. ROP participants (n = 69) had <2 years
of prior antipsychotic treatment; the HC group (n = 79)
had no major mental illness. Participants viewed 10 pictorial warnings, 8 videos depicting similar messages, and
were interviewed regarding tobacco use, health literacy,
and smoking knowledge. We assessed response at baseline and at 4-week follow-up. ROP participants were more
likely than HC to smoke tobacco (49.3% vs 10.1%) and
had lower levels of health literacy and smoking-related
knowledge. Cannabis was used by 46.4% of ROP participants. Effectiveness ratings were high for both picture and
video warnings with no differences between media. ROP
participants compared to HC and nonsmokers compared
to smokers were more likely to perceive warnings as effective. Effectiveness was associated with negative affect and
greater emotional arousal. We assessed 33 smokers at follow-up; 5 (15%) identified as nonsmokers, 15 (45%) made
a quit attempt, and 16 (49%) reported that the warnings
influenced their smoking. Results indicate that young people with psychotic disorders respond favorably to health
warnings. Effective messages depict health consequences
clearly, elicit negative emotions, and may impact smoking behavior. Future research is needed to understand the
effects of mode of presentation and message comprehension on smoking behavior.
Key words: schizophrenia/cigarette smoking/health
warning labels/mental illness/health literacy

Introduction
Tobacco smoking remains the leading preventable cause
of mortality in the United States.1 Smoking rates have
declined in the United States and internationally2,3 partially due to public health interventions that restrict
tobacco-related marketing and improve education about
smoking-related health consequences.4 However, smoking rates remain high in persons with mental illness, and
schizophrenia in particular. Smoking prevalence among
persons with psychosis range from 44% to 77%,5–10 with
over 50% of 404 participants with first episode psychosis
reporting current smoking in a recent treatment study.11
People with severe mental illness (SMI) are also more
likely to be heavy smokers (>1 ppd),12 less likely to quit,13
and die up to 25 years earlier than the general population,
primarily due to smoking-related cardiac illness.14 Almost
one-third of current smokers in the United States have a
mental illness15 and smoking accounts for over half the
illness-related deaths in persons with schizophrenia.16
Public health initiatives such as the WHO Framework
Convention on Tobacco Control17 and legislation such
as the Family Smoking Prevention and Tobacco Control
Act in the United States (FSPTCA; 2009) have contributed to declining smoking rates by promoting economic
and educational disincentives to use tobacco, targeting
high-risk groups for education (including adolescents,
young adults, and persons with mental illness18), and
encouraging evidenced-based cessation treatments. These
initiatives guide tobacco-related health message dissemination, including the placement of graphic warning
labels (GWLs) on tobacco products. Disseminating vivid
depictions of smoking consequences has been associated
with population-based changes in smoking attitudes.
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Less change is noted in countries that have not yet implemented GWLs.19 Prior research suggests that effective
smoking-related health warnings are large, prominently
displayed, and combine pictorial images with words.20
Images illustrating negative health effects of smoking are
more effective than other image types, and pictures evoking strong emotions are more effective than less evocative images.20 US implementation of GWLs has been
delayed by litigation from the tobacco industry.21 Health
warnings target both nonsmokers to prevent smoking
initiation as well as smokers to encourage cessation.
Educational initiatives frequently target adolescents, the
critical age period for initiating smoking.22 Adolescents’
and young adults’ responses to smoking-related health
warnings suggest that they notice and retain information
about health warnings.23,24 Young smokers, however, may
perceive messages as less salient and less likely to influence smoking behavior25 than older smokers.26 Youth are
also more likely to recall and respond to health messages
with personal testimonials, a novel narrative, and high
message sensation value (MSV).27,28
Video format health messages appear on television and
also on unregulated internet sites such as YouTube that
are popular among youth. A YouTube content analysis
found that more frequently viewed and discussed antismoking videos had higher MSV; however, humorous
messages with high MSV are less popular and subvert
antismoking messages by reducing credibility.29 We are
unaware of published research comparing the effectiveness of video communications to static pictorial messages.
Examining the impact of new media on health messaging
is warranted, because both tobacco promotion and antismoking messages now widely appear in this medium.
Despite high smoking rates among young persons with
psychotic disorders, the temporal association between
age of smoking onset and of psychotic symptoms, and
data suggesting that changes in tobacco use may be associated with prodomal and psychotic symptoms,9 there are
virtually no data assessing the impact of health-related
warnings in this vulnerable group. This gap stands in
stark contrast to evidence that patients with psychotic
disorders have been the target of tobacco industry marketing efforts to promote smoking and normalize the
behavior among mental health clinicians.30 To fill this gap,
we investigated perceptions of effectiveness and affective
responses to smoking-related health warnings in young
people with recent-onset psychosis (ROP) and in a comparison group of persons without mental illness. Message
formats included pictorial warnings and brief video-clips.
We assessed smoking-related knowledge and examined
the effects of message viewing on subsequent knowledge
and behavior. We hypothesized that (a) people with ROP
would perceive warnings as less effective than a healthy
comparison (HC) group; and that (b) video warnings
would be perceived as more effective and processed more
intensely than picture/text warnings. We also examined

the demographic, clinical, and behavioral predictors of
responses to the health messages.
Methods
Design
We assessed ROP and HC participants at baseline, presented the health warnings within a structured protocol,
and assessed responses to the warnings immediately and
4 weeks later.
Setting and Participants
The investigation was conducted at an academic medical center serving a socioeconomically diverse urban
and suburban catchment area. Eligible participants
were tobacco smokers and nonsmokers ages 15 to 40
with no cognitive impairments hindering informed consent or study completion. Written informed consent was
obtained to participate (or parental consent and written
assent for participants <18) for this IRB-approved investigation. Data were collected between January, 2013 and
March, 2015.
Participants were recruited from specialized earlyphase psychosis programs. Eligible participants had a
diagnosis of schizophrenia, schizophreniform disorder,
schizoaffective disorder, or psychotic disorder NOS,
and less than 2 years of prior antipsychotic treatment.
Exclusion criteria included medical impairments, substance-induced psychotic disorder, psychotic symptoms
preventing study completion, or acute risk of suicidal/
homicidal behavior. Initial diagnostic eligibility was
confirmed by the Structured Clinical Interview for Axis
I DSM-IV Disorders (SCID).31 These data were later
reviewed in a consensus conference32 for final diagnostic
assignment.
HC participants were recruited from the local community with promotional flyers. Exclusion criteria included
taking psychotropic medications or meeting criteria for
any current Axis I disorder except simple phobias on a
SCID-NP interview.33
Procedures
After assessment of clinical status, tobacco use history,
smoking characteristics, smoking knowledge and health
literacy, participants viewed 18 health warnings in random order for a minimum of 15 seconds each. Videos and
text/picture warnings were interspersed and sequencing
was randomized to control for order effects. After viewing each warning, participants rated its effectiveness and
their emotional response to the warning. After viewing
all stimuli, participants were asked to formulate as many
questions as possible about smoking. Repeat assessment
of smoking-related knowledge, attitudes, and behavior
occurred 4 weeks later.
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Health Warnings

Smoking and Health Knowledge

Nine print warnings from the proposed US cigarette
labels34 were supplemented with 10 GWL images from
other countries.35–38 We selected messages using younger
models that depicted relevant messages for young people
(eg, smoking affects physical appearance or sexual functioning). All warnings were formatted to conform to the
text, typography and layout of the US warnings.
These 19 preliminary images were presented at two
90-minute focus groups attended by 3 men and 3 women
with schizophrenia (4 smokers and 2 nonsmokers, mean
age = 29.62, SD = 6.12). Group content analysis suggested that effective warnings depicted actual individuals
(as opposed to cartoon drawings or abstract/nonhuman
images) and elicited strong negative emotions (eg, sadness, empathy, or disgust). Participants had difficulty
grasping some of the relationships between the health
warning text and associated pictures. Effective messages
clearly explained the health consequence depicted in the
picture. Ten warnings were selected for subsequent study
based on focus group efficacy ratings.
Eight videos with equivalent health-related messages
were developed. Educational messages paralleled the
text/picture warnings, lasted 2 minutes or less, deployed
a testimonial style demonstrated to be preferable in prior
research with young people,39,40 included young actors
from diverse ethnic/racial backgrounds, and ranged in
emotional tone from light and humorous to dark and fearinducing. The final set of warnings is shown in figure 1.

Participants completed an 18-item smoking knowledge
questionnaire developed for this investigation. This
questionnaire used simple dichotomous questions based
broadly on content areas used in prior research among
participants with psychotic disorders.46 Preliminary
psychometric examination indicated good internal consistency (α = 0.78) suggesting that we were tapping an
underlying “smoking knowledge” construct. Participants
also completed the short-form of the Test of Functional
Health Literacy (S-TOFHLA)47 to assess participants’
abilities to process and apply health-related information.

Clinical Assessments
Current psychiatric functioning, positive symptoms, and
current depressed mood were assessed with the Brief
Psychiatric Symptom Rating Scale- A (BPRS-A)41 and
negative symptoms with the Hillside Clinical Trials version of the Schedule for the Assessment of Negative
Symptoms (SANS).42 Assessments were performed by
trained Doctoral- or Master’s-level psychometricians.
Smoking and Related Characteristics
A Smoking Behavior and Engagement Battery was
developed including (a) items assessing quantity/frequency of current smoking behavior and quit attempts.
Current smoking was defined as any cigarette use in the
past 30 days and >100 cigarettes smoked lifetime. This
battery also included (b) a Likert-scale item assessing
recent health warning exposure, (c) The Fagerstrom
Test of Nicotine Dependence (FTND)43 to assess
smoking behavior in current smokers; and (d) selected
items from the Population Assessment of Tobacco and
Health survey to obtain current and prior tobacco
product use.44 Tobacco-related marketing exposure
was assessed using a 17-item checklist used in tobacco
research in youth.45
1258

Perceptions of and Responses to Health Warnings
Participants rated warning effectiveness using 5-point
Likert-scale items adapted from a study of young smokers’ reactions to warning labels.48 Items tapped each message’s effectiveness at (a) preventing smoking initiation; (b)
encouraging quit attempts; and (c) increasing concern about
the impact of smoking on health. Emotional response was
rated on 9-point visual analog scales using the Valence
(degree of positive/negative affect) and Arousal items of the
Self-Assessment Manikin (SAM).49 After rating all stimuli,
participants were asked to formulate questions about smoking, guided by a structured question eliciting protocol50 used
in interventions to activate patients in psychiatric51 and primary care medical treatment.52 Participants were encouraged
to produce as many questions as possible in response to the
following eliciting statement or question focus: “questions
to help you make decisions about smoking cigarettes.”50
Data Analysis
We used t tests for independent means to evaluate differences between continuous variables and χ2 analyses to
test differences among categorical variables. Univariate
analyses were conducted to compare variables according
to study group (ROP vs HC).
Each patient generated measures of perceived effectiveness, affect, and arousal for each of the 18 stimuli;
item analysis procedures identified good-to excellent
internal consistency within the 3 effectiveness questions for both picture/text warnings (mean Chronbach’s
α = 0.88, range = 0.82–0.94) and videos (Mean α = 0.89,
range = 0.82–0.94). A total effectiveness score (score
range 3 to 15) was computed for each health warning,
and 2 summative effectiveness scores were calculated
according to message modality (picture/texts and videos).
A matrix of bivariate Pearson r analyses examined patterns of association between perceived effectiveness and
affective dimensions (valence and arousal).
Exploratory t tests compared ratings for each stimulus
according to study group followed by a 2-way analysis
of variance (ANOVA) to evaluate interactions between
study group (ROP vs HC) and smoking status on perceived warning effectiveness.

Responses to Smoking-Related Health Messages

Fig. 1. Final set of tobacco-related health warnings.34–38

A multiple linear regression analysis was conducted to
identify significant predictors of perceived warning effectiveness from among demographic, clinical, and smoking-related dependent variables. Backward elimination
procedures were used until the model only contained variables with P values < .05. Significance tests were generally
set at α = 0.05 except for exploratory analyses of the 18
warning stimuli, where a Bonferroni multiple comparison
correction was applied. Analyses were completed using the
Statistical Package for the Social Sciences (SPSS) V. 22.
Results
Overall, 158 individuals consented to participate (77 with
ROP and 81 HC) and 148 (69 patients with ROP and 79
HC) viewed all the health warnings and completed initial

assessments. ROP participants met DSM-IV criteria for
Schizophrenia-undifferentiated type (n = 34), paranoidtype (n = 19), Schizoaffective Disorder (n = 4) Psychotic
Disorder NOS (n = 2), or Schizophreniform disorder
(n = 10). Follow-up assessments were obtained from 117
participants (79% of those who viewed the health warnings; 53 with ROP and 64 HC).
Participants with ROP were approximately 5 years
younger (t = 5.93, df = 146, P < .001), more likely to be
male (χ2 = 26.24, df = 1, P < .001), and had lower levels of
education (χ2 = 55.70, df = 4, P < .001; table 1). Both groups
were racially diverse; Hispanic ethnicity was more common
among the ROP vs HC group (χ2 = 4.16, df = 1, P = .04).
Antipsychotic treatment among ROP participants
by frequency were: risperidone (n = 51 or 74%),
1259
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Table 1. Demographic and Clinical Characteristics
Characteristic
Demographic variables
Male (%)
Mean age (SD)
Ethnicity (% of Hispanic origin)
Race (%)
Caucasian
African American
Asian
Mixed race/other
Level of education (%, n = 64)
≤High school graduate
High school graduate
Some college
College graduate
Graduate degree
Smoking variables
Current smokers
Fagerstrom total score (in smokers)
Smoking knowledge (M, SD, n = 63)
Health literacy (S-TOFHLA) (M, SD)
Number of smoking-related questions

Recent-Onset Psychosis
(n = 69)

Healthy Comparison Group
(n = 79)

Statistics

55 (79.7%)
22.67 ± 5.2
13 (18.8%)

30 (38%)
27.97 ± 5.6
8 (7.6%)

χ2 = 26.24, df = 1, P < .001
t = 5.93, df = 146, P < .001
χ2 = 4.16, df = 1, P = .04

25 (26.2%)
22 (31.9%)
15 (21.7%)
7 (10.1%)

38 (48.1%)
22 (27.8%)
16 (20.3%)
3 (3.8%)

χ2 = 3.66, df = 3, P = .30

22 (31.9%)
14 (40.63%)
28 (40.6%)
3 (4.3%)
2 (2.9%)

0 (0%)
7 (10.9%)
16 (25%)
22 (34.4%)
19 (29.7%)

χ2 = 55.70, df = 4, P < .001

34 (49.3%)
2.36 ± 2.16
84.57 ± 17.95
30.44 ± 6.9
12.12 ± 6.25

8 (10.1%)
2.37 ± 1.77
91.71 ± 7.93
35.24 ± 1.1
17.36 ± 11.35

χ2 = 27.77, df = 1, P < .001
t = 0.15, df = 39, P = .99
t = 3.17, df = 140, P = .002
t = 6.13, df = 146, P < .001
t = 3.41, df = 145, P < .001

Note: S-TOFHLA, Test of Functional Health Literacy.
Table 2. Clinical Profile of Participants With Recent-Onset Psychosis (ROP, n = 69)
Characteristic
Positive symptoms
BPRS (total score)
BPRS-hallucinatory behavior
BPRS-conceptual disorganization
BRPS-unusual thought content
BPRS-depression
Negative symptoms
SANS-affective flattening
SANS-alogia
SANS-avolition
SANS-asociality-anhedonia
Comorbid substance abuse disorder
Comorbid alcohol abuse disorder
Medication treatment
Risperidone
Aripiprazole
Olanzapine
Clozapine
Haloperidol
Quetiapine
Quetiapine+Aripiprazole

M ± SD

Nonsmokers (n = 35)

Smokers (n = 34)

Statistics

30.35 ± 8.56
2.39 ± 1.58
1.51 ± 0.98
2.72 ± 1.61
1.84 ± 1.13

27.41 ± 6.85
2.17 ± 1.38
1.40 ± 0.91
2.43 ± 1.29
1.54 ± 0.82

33.29 ± 9.17
2.62 ± 1.76
1.62 ± 1.04
3.03 ± 1.85
2.14 ± 1.33

t = 2.98, df = 66, P = .004
t = 1.18, df = 67, P = .25
t = 0.92, df = 67, P = .36
t = 1.57, df = 67, P = .12
t = 2,28, df = 67, P = .03

1.87 ± 0.79
1.46 ± 0.76
1.88 ± 0.76
1.74 ± 0.80
32 (46.4%)
17 (24.6%)

1.85 ± 0.74
1.32 ± 0.53
1.91 ± 0.79
1.60 ± 0.69
9 (25.7%)
8 (22.9%)

1.88 ± 0.86
1.62 ± 0.92
1.85 ± 0.76
1.88 ± 0.88
23 (67.6%)
9 (26.5%)

t = 0,13, df = 65, P = .90
t = 1,61, df = 66, P = .11
t = 0.33, df = 65, P = .74
t = 1.48, df = 67, P = .14
χ2 = 12.19, df = 1, P < .001
χ2 = 0.12, df = 1, P = .73

51 (73.9%)
10 (14.5%)
2 (2.9%)
2 (2.9%)
2 (2.9%)
1 (1.5%)
1 (1.5%)

Note: BRPS, Brief Psychiatric Symptom Rating Scale.

aripiprazole (n = 10 or 14.1%), haloperidol (n = 2 or
2.9%), olanzapine (n = 2 or 2.9%), clozapine (n = 2
or 2.9%), quetiapine (n = 1 or 1.5%) and combination aripiprazole and quetiapine (n = 1 or 1.5%). ROP
participants had relatively low levels of positive and
negative symptoms at baseline and mean BPRS total
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scores were in the mildly ill range.53 Thirty-two ROP
participants (46.4% of ROP participants) had comorbid substance abuse disorders. All had a cannabis use
disorder; additional diagnoses included cocaine abuse
(n = 2), opioid abuse (n = 1), and polysubstance dependence (n = 1).
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Nicotine dependence among smokers was in the low
range in both groups. Just under half of the ROP group
reported current tobacco smoking (n = 34 or 49.3%)
compared to 10% of the HC group (χ2 = 27.77, df = 1,
P < .001). Health literacy levels were high overall (with
138/148 or 93.5% of all participants in the “adequate”
range of functioning); however, participants with ROP
had lower mean health literacy scores (t = 6.13, df = 146, P
< .001) and lower levels of smoking knowledge (t = 3.17,
df = 140, P = .002). Smokers with ROP had higher mean
total BPRS scores (P = .004), higher BPRS Depression
Scores (P = .03) and were more likely to have comorbid
substance abuse (P < .001).
Exploratory examination of knowledge item
responses suggested that a greater proportion of
ROP participants believed that smoking “does not
increase the chances of young people having a stroke”
(P = .001), “only affects the brain if you smoke for
10 years or longer” (P = .02), and that it took “years
of smoking before you have trouble quitting” (P = .04).
ROP participants also were more likely to endorse that
smoking “did not increase risks of emphysema or lung
disease” (P = .003), heart disease (P = .005), cancer
(P = .04), or miscarriage (P = .01). Finally, ROP participants were also more likely to perceive that smoking
“did not reduce the amount of oxygen the baby gets” in
pregnant women (P = .04) or believe that arsenic was a
cigarette ingredient (P = .04).

Perceptions of Health Warning Effectiveness
Over 90% of participants perceived the health warnings as
effective. Only 12 subjects (8.1%) rated pictures as less than
moderately effective, and only 14 participants (9.5%) rated
videos as less than moderately effective. We observed high
mean effectiveness ratings for both the set of 10 pictures
(12.28 ± 2.04) and the 8 videos (M = 12.20 ± 2.19) that were
not statistically different (t = 0.68, df = .146, P = .50).
Perceived Effectiveness and Affective Response
The association between perceived effectiveness and
affective response (positive/negative valence and arousal)
was assessed for each stimulus (table 3). Moderate-tohigh associations were observed (mean r = 0.42 ± 0.11)
between effectiveness ratings and valence, with greater
effectiveness associated with more negative or sad affective response. The strength of association was weaker in
response to health messages that used humor to deliver
the health warning. Significant but more modest associations were observed between perceived effectiveness and
arousal level (mean r = 0.28 ± 0.09), with more effective
messages evoking greater levels of arousal/stimulation.
Perceived Effectiveness, ROP, and Smoking Status
Given the similar effectiveness and arousal ratings for
picture text warnings and videos, these 2 scores were

Table 3. Associations Between Perceived Effectiveness and Affective Response (Valence and Arousal) in Total Sample
(n = 148)
Stimulus/ Message

Picture A: Smoking isn’t pretty.
Picture B: Cigarettes cause heart disease.
Picture C: Smoking causes fatal lung disease.
Picture D: Smoking contains benzene, nitrosamines, formaldehyde, and hydrogen cyanide.
Picture E: Smoking is a major cause of strokes.
Picture F: Secondhand smoke can cause stillborn births, low birth weight, and other
pregnancy problems.
Picture G: Smoking causes impotency.
Picture H: Cigarettes are addictive.
Picture I: Smoking causes premature births.
Picture J: Cigarettes are addictive.
Video A: Smoking is addictive.
Video B: Smoking causes lung cancer.
Video C: Smoking causes heart attack.
Video D: Cigarettes contain harmful chemicals.
Video E: Smoking causes impotence.
Video F: Smoking harms physical appearance.
Video G: Smoking harms the developing fetus.
Video H: Secondhand smoke causes disease.
Mean

Association Between Perceived
Effectiveness
Valence (r)

Arousal (r)

0.54***
0.41***
0.47***
0.50***
0.49***
0.30***

−0.36***
−0.33***
−0.21**
−0.32***
−0.39***
−0.12

0.45***
0.42***
0.42***
0.57***
0.43***
0.55 ***
0.46***
0.40***
0.25**
0.19*
0.53***
0.52***
0.43 ± 0.11

−0.35***
−0.39***
−0.01
−0.29***
−0.28***
−0.29***
−0.34***
−0.25**
−0.25**
−0.31***
−0.27***
−0.32***
−0.28 ± 0.09

Note: *P < .05; **P < .01; ***P < .001.
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combined for subsequent analyses. Two-way ANOVA identified significant main effects for smoking status (F = 8.60,
df = 3,143, P = .004) and illness group (F = 6.37, df = 3,143,
P = .01) on perceived effectiveness. Post hoc examination
of scores revealed that ROP participants perceived warnings as “more effective” (M = 12.47, SD = 2.12, range = 5
to 15) than healthy controls (M = 12.04, SD = 1.96), and
nonsmokers in both study groups (M = 12.44, SD = 1.90)
perceived warnings as more effective than smokers
(M = 11.74, SD = 2.30). Multivariate regression analysis
(table 4) identified only smoking status and illness group
as significant predictors of perceived effectiveness from
among the set of potential variables including demographics (age, sex, ethnicity) smoking-related knowledge
scores, and health literacy scores (F value for the final
model = 4.67, df = 2,147, P = .01).
Response to Health Warnings at Follow-up
One month after viewing the warnings, HC compared
with ROP participants were more likely to have discussed the health warnings (χ2 = 8.24, df = 1, P = .004)
and were able to generate more smoking-related questions (t = 3.41, df = 145, P < .001). Participants in both
groups reported significantly greater attention to health
warnings at the follow-up assessment when compared to
their recollections in the month prior to viewing the study
warnings (F = 12.61, df = 1,1,111, P < .001). Betweengroups analysis indicated that change in level of attention was greater in ROP than HC participants, but this
finding failed to attain statistical significance (F = 3.68,
df = 1,1,111, P = .06).
Of the participants returning for follow-up, 5 (15%) of
the 33 smokers identified as “nonsmokers” at follow-up
(4/27 with ROP and 1/6 HC), and an additional 10 ROP
participants reported making 1 or more quit attempts.
Five participants had tried nicotine replacement, and
1 had joined a quit program. None initiated smoking
between baseline and follow-up. Just under half of the
follow-up sample of smokers (16/33 or 48.5% of baseline smokers and 10/15 or 66.7% of the quit attempters)
reported that their decisions about smoking were at least
somewhat influenced by the health warnings. Among
smokers, quit attempters perceived the health warnings
as eliciting more negative affect than nonattempters
(t = 2.46, df = 30, P = .02).
Table 4. Variables Significantly Associated With Perceived
Effectiveness to the Health Warnings
Independent Variable

B

SE

β

t Value

P

Group (ROP vs HC)
Smoking status

−1.72
−2.22

0.73
0.80

−0.21
−0.25

−2.37
−2.76

.019
.006

Note: HC, healthy comparison; ROP, recent-onset psychosis.
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Discussion
To our knowledge this is the first report documenting
reactions to health warnings in persons with schizophrenia, the first to compare the reactions of persons with
schizophrenia to healthy controls, and the first report
comparing responses to picture/text warnings and brief
video messages. ROP participants were more likely to
be current tobacco smokers and had limited knowledge
of smoking-related health risks. Overall, both pictorial
and video health warnings were rated as highly effective. Controlling for demographic and pre-assessment
knowledge and literacy differences, ROP participants
perceived health warnings as more effective than healthy
controls. The ranking of perceived warning effectiveness
was: nonsmokers with psychotic disorders (highest effectiveness), followed by healthy nonsmokers, smokers with
psychotic disorders, and healthy smokers (least effectiveness). Results suggest that health messages containing
clear messages delivered with pictures or video are highly
relevant in this population.
Perceived warning effectiveness was associated with
higher negative affect and emotional arousal, particularly
for serious messages depicting life-threatening health
consequences. These results are broadly consistent with
tobacco message findings with the general youth population24,28 and suggest that pictorial health warnings are not
contraindicated in people with psychosis.
Contrary to our hypothesis, participants responded
equally to video and picture/text warnings. This supports
the use of both pictorial and video media messages to
motivate and educate young people with psychotic disorders, as well as disseminating clearly presented, lossframed and arousing pictures on cigarette packages. Of
note, we excluded messages depicting cartoons, x-rays
and other abstract concepts that were not well understood in the initial ratings by ROP participants.
During the month following structured health warning exposure, participants responded to them cognitively
and behaviorally. Remarkably, 45.4% of the participants
reported they tried to quit and 15% became abstinent.
Prior research testing the impact of health warnings on
subsequent behavior has shown variable and modest
results.54 Our findings are broadly consistent if not slightly
higher than studies examining relations between health
warning exposure and subsequent quit attempts.55,56 Our
results contrast with the only study of attitudes about
smoking-related health warnings in persons with psychotic disorders, in which qualitative analysis of interviews suggested that health warnings may not only fail to
motivate smokers with psychosis to quit, but in fact may
cue viewers to the perceived benefits of tobacco use.46
This exploratory investigation has limitations. First,
our HC group was a convenience sample recruited by
advertisements rather than a matched control group.
The HC sample was older, and had a different sex and

Responses to Smoking-Related Health Messages

educational distribution. Analyses of interactions
between illness group and smoking status on warning effectiveness may have been subject to Type II error
related to the low prevalence of smoking in the HC group.
Second, we recruited participants from a single site in an
area with high tobacco taxation rates and widely disseminated, multimedia, and graphic antismoking campaigns.
Observed warning response may have been influenced by
exposure to prior messages. By design, our protocol facilitated processing of multiple health messages to obtain
participants’ responses to them, unlikely to occur in realworld settings. Thus the 1-month follow-up behavioral
responses are likely magnified. Further, without a control
condition we cannot confirm that the impact reported at
follow-up was not due to study assessments, unmeasured
factors, or chance. Fourth, 31 subjects were lost to follow-up and this may have skewed the data on subsequent
smoking behavior. Finally, we limited our area of inquiry
to perceived effectiveness and affective response to health
warnings as these are previously identified predictors of
health warning impact on future smoking behavior.57
Our results nonetheless identify important areas for
future study. Our ROP participants who did not smoke
responded positively to the warnings; suggesting exploring if graphic warnings could prevent smoking initiation
in this highly vulnerable population. Our relatively lowintensity intervention (processing a series of warnings
on a computer monitor) impacted short-term smoking
behavior in ROP smokers. This challenges conceptions
that attitudes and behavior in this population are unmalleable. Overall, our results show that public health efforts
using graphic warnings, presented in a distraction-free
environment, can reach young people with psychotic
disorders. This group may need more education about
smoking-related health consequences, and help translating messages into concrete long-term behavior change.
Future research could compare responses to graphically
rich messages and existing text-based warnings, and
describe how messages are processed in real-world environments—eg, when they are disseminated on cigarette
packaging through media campaigns and through strategic placement in locations where cessation support and
education might be obtained (eg, in mental health clinic
environments, waiting rooms, offices, etc.).
Future research might also examine interrelations
among smoking knowledge, warning comprehension,
and other social-cognitive variables known to mediate
health-related decision making in general58 and smoking behavior in persons with SMI.59–61 Causal pathways
between viewing health warnings and subsequent behavior are inadequately understood in general populations55
and have yet to be studied in persons with SMI. Finally,
our findings raise the possibility that pictorial and video
health warnings could be incorporated into motivational
interventions and cessation decision support tools targeting ROP smokers. The environmental context in which

these interventions are implemented would need to assess
potential barriers to implementation related to cultural
norms normalizing tobacco use within mental health
treatment environments.62
In summary, young people with schizophrenia
responded positively to graphic health warnings.
Exposure to and processing of these messages led to
cognitive and behavioral cessation activity. Given the
ongoing high rates of smoking initiation and persistence leading to early morbidity and mortality in this
group, future research is warranted to explore the role
of these messages in addressing tobacco use disorder in
schizophrenia.
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